Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 163 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis

Relapsing Multiple Sclerosis Germany

Remibrutinib in Real-world Clinical Practice - a US Sub-study

Chronic Spontaneous Urticaria United States

A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients

Chronic Spontaneous Urticaria United States

Remibrutinib in Real-world Clinical Practice

Chronic Spontaneous Urticaria United States

Implementation Study to Describe and Compare Retention Rate and Adherence to Adjuvant Therapy With Ribociclib With and Without Usage of Mobile Application in Patients With HR+ HER2-negative Stage II and III Breast Cancer in Real-world Practice

Breast Cancer Russia

Real-world Secukinumab Outcomes in Canadian HS Patients

Hidradenitis Suppurativa Canada

Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With Dyslipidemia

Atherosclerotic Cardiovascular Disease Phase4 United Arab Emirates

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

Primary Immune Thrombocytopenia, Warm Autoimmune Hemolytic Anemia Phase2 Czechia

A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate Cancer

Metastatic Prostate Cancer (mCRPC) Phase1 Japan

Ilaris NIS in Korea

Hereditary Periodic Fever Syndromes, Cryopyrin-associated Periodic Syndromes (CAPS), Colchicine Resistance Familial Mediterranean Fever (crFMF), TNF Receptor Associated Periodic Syndrome (TRAPS), Hyper-IgD Syndrome / Mevalonate Kinase Deficiency (HIDS/MKD), Systemic Juvenile Idiopathic Arthritis (sJIA) South Korea